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Invasive cardiologists who lived through the early years of
balloon angioplasty remember those initial terrible moments
when we realized something was very wrong. The ST-
segments were rising, the blood pressure was falling, and we
heard our patient utter that dreadful statement, “Doc, I feel
like I’m gonna die.” We knew right then it was going to be
a long day in the cath lab. It is easy to forget that in the early
days of balloon angioplasty 1% to 2.5% of patients died and
1.9% to 5.8% required urgent coronary artery bypass graft
(CABG) surgery (1–3).
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The incidence of emergency CABG surgery after failed
percutaneous coronary intervention (PCI) clearly has di-
minished over the last 20 years (4). The American College
of Cardiology/American Heart Association Guidelines for
PCI cites an incidence of 0.2% to 3% for emergency surgery
after elective PCI (3). In the registry of The Society for
Cardiac Angiography and Interventions from 1996 to 1998,
0.3% to 0.7% of all patients who received PCIs required
emergency CABG surgery (5). Recently in a survey of
18,593 patients receiving PCIs from the Cleveland Clinic,
the need for emergency CABG surgery decreased from
1.5% in 1992 to 0.14% in 2000 (6). In addition to defining
the incidence of emergency CABG surgery, these and other
studies identify the many clinical, procedural, and lesion-
related variables associated with a higher likelihood of
emergency CABG surgery. Patients with acute coronary
syndromes, including ST-segment elevation myocardial in-
farction (STEMI), important baseline hemodynamic abnor-
malities and complex lesion morphology, such as calcifica-
tion, angulation, and thrombus, are at greater risk (3). As
the techniques for PCI evolved and results improved, it was
only natural we pushed the envelope to treating unstable
patients, those with STEMI and more complex and difficult
lesions subsets.
The article by Lotfi et al. (7) in this issue of the Journal
indirectly asks an important question that is becoming more
relevant as some desire to push the envelope to the setting
of elective PCI in laboratories without on-site cardiac
surgery. The question is: What if something really goes
wrong and there is a delay before urgent CABG surgery? If
you have performed enough PCIs, you know how awful that
delay feels. There you are, standing in the laboratory
watching your patient with an occluded or perforated artery
that you cannot fix deteriorate before your eyes despite your
best efforts. The surgeon is coming, but the minutes it takes
for the operating room crew to arrive seem like hours.
Perhaps us “old doctors” remember this better because it
happened more frequently to us in the past than it does to
the newer generation of interventional cardiologists. After
all, we now have a better knowledge of who is at risk, we
have perfusion balloons, glycoprotein IIb/IIIa antagonists,
better thrombin inhibitors, and stents. Nevertheless, the
question remains important because of a simple fact. Al-
though the risk of PCI failure resulting in urgent CABG
surgery is now very low, it is not zero. Lotfi et al. (7) attempt
to define the key issue: What is the potential for harm if
something really goes wrong and surgery is delayed?
IS THEIR ANSWER CORRECT?
To answer this question, Lotfi et al. (7) carefully identified
all patients having urgent CABG surgery after failed PCI at
their facility, a tertiary care hospital with experienced
operators performing roughly 1,500 PCIs per year. Al-
though the number of operators is not provided, this fits
every definition of a high-volume laboratory. During this
time period, 45 patients (0.7%) required CABG surgery
during the same hospital admission. In our current era, we
realize that many times even if things go badly during PCI,
we can stabilize the patient and avoid the all-out rush to the
operating room. Accordingly, the authors had three pre-
specified criteria that they used to identify patients who
most likely could be harmed if surgery were delayed. Their
three criteria were hemodynamic instability, severe isch-
emia, and coronary perforation with effusion or tamponade.
These criteria could be debated but seem reasonable based
on published studies of outcome after urgent CABG surgery
for failed PCI (3,6,8–13). Using their criteria, one to two
patients per 1,000 PCIs might be in big trouble if they
experienced a delay before CABG surgery for a failed PCI,
a reasonable number equivalent to other contemporary data
from high volume programs (6,8,9,11–14). Some might
quibble, saying that this is just a “potential for risk” and, in
fact, they have not demonstrated that patients were harmed
by waiting or that patients actually had a better outcome
with immediate versus delayed surgery despite meeting their
criteria for an urgent situation. We must concede that point,
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but does common sense always need verification in a
randomized trial?
IS THEIR ESTIMATE
RELEVANT TO THE REAL-LIFE QUESTION?
Lotfi et al. (7) derived their data from experienced operators
working in a high-volume laboratory at a tertiary care
hospital. As such, the authors basically treated “all comers.”
About half were urgent PCI procedures and, by our esti-
mate, approximately 65% of the lesions observed were of
type B2 or C morphology, both of which are associated with
a higher risk of adverse outcome. The relevant question,
however, is not “What if something goes wrong at a tertiary
care hospital with an operating room down the hall?”
Indirectly but very clearly, the authors demonstrate that
answer—100% of their patients who had the prespecified
criteria were in the operating room in  2 h. The relevant
question is “What if something really goes wrong when
elective PCI is being performed at a hospital without on-site
cardiac surgery?” In that regard, the study of Lotfi et al.
leaves some remaining questions.
Several groups have reported their experience with elec-
tive PCI at hospitals without on-site cardiac surgery (15–18).
The most recent comes from Ting et al. (18), who work in
a laboratory 85 miles from the nearest hospital with on-site
cardiac surgery. Their report never states how many patients
were evaluated and then referred to a hospital with on-site
surgery, but certainly there were some. Even the strongest
advocates of elective PCI without on-site cardiac surgery
recommend stringent screening criteria designed to identify
low-risk patients with a high likelihood of success. To that
end, Ting et al. (18) describe treating 196 clinically stable
patients with type A or B1 lesions, a system where images
could be transmitted to the supporting hospital for imme-
diate consultation, and a “fail-safe” transportation protocol,
including the confirmed availability of three separate heli-
copter ambulances, two ground ambulances, and a fixed-
wing air ambulance. Moreover, cases were cancelled or
delayed if there was inclement weather that could interfere
with transport (18). They report procedural success in
99.5% of the procedures and one late in-hospital death that
was not related to a lack of on-site surgery. However, given
their small sample size, the 95% confidence interval for
death was 0.01% to 2.8%, the latter number clearly excessive
for elective PCI by today’s standards.
Because Lotfi et al. (7) made their determination in the
absence of any screening to exclude high-risk clinical or
lesion subsets, it is logical to assume that if such patients
were excluded, the actual number of patients at risk would
be lower. In fact, all of their patients who required urgent
CABG surgery and manifested one of their prespecified
criteria had type B2 or C lesions. Theoretically, these
patients would be excluded from treatment in Ting’s labo-
ratory, making the solution very simple. If you want to avoid
trouble, simply exclude type B2 and C lesions. That would
make everything very easy if it were true, but there are data
to the contrary. In two large contemporary surveys of PCIs,
both with a high usage of coronary stents, 5% and 15% of
those requiring emergency CABG surgery had type A lesion
morphology (6,12). This reminds us that it is not always the
lesion causing the problem. Guiding catheters are stiffer and
less forgiving than diagnostic catheters and some, such as
the Amplatz and multipurpose, can unexpectedly jump
deeply onto the coronary artery, causing vascular trauma.
Reports of left main dissection secondary to guide catheter
manipulation also exist (19). Although the number of
patients at risk for harm may be overestimated by Lotfi et al.
(7), one must respect the fact that despite every precaution,
an adverse event requiring urgent CABG surgery may
occur.
ARE WE NOT ALREADY PUSHING THE ENVELOPE?
Data continue to accumulate that urgent PCI for reperfu-
sion in the setting of STEMI is not only equivalent but in
some respects superior to fibrinolytic therapy (20,21). We
have already started to push the envelope to emergency PCI
for STEMI at hospitals with cardiac catheterization labo-
ratories but without on-site cardiac surgery (22–24). The
most recent American College of Cardiology/American
Heart Association PCI guidelines state this is acceptable
under certain well-defined circumstances (3). Is elective PCI
without surgical back up not the next logical step in this
progression? Some will argue it is, but it is critical to make
the distinction between urgent PCI for acute STEMI and
elective PCI. In the setting of STEMI, our treatment goal
is to prevent mortality or reduce the morbidity associated
with the loss of viable myocardium, and this is well
supported in the literature (3,23). Time is also critical
because the sooner the artery is opened, the better the
outcome. Much of what we do in medicine is a balance of
risk versus benefit; for example, the risk a medication will
cause a bad side effect versus the benefit for treating a
condition. It is no different for the situation of PCI for
STEMI at hospitals without on-site cardiac surgery. We are
balancing the risks (stroke if fibrinolysis is used, need for
transfer should emergency CABG surgery be required,
vascular complications) versus the benefits (salvage of myo-
cardium, reduced mortality, shortened length of stay). In
this setting, pushing the envelope to PCI for STEMI at
hospitals without on-site surgery is an attempt to provide a
potential life-saving and muscle-sparing procedure to as
many patients as possible in the fastest time possible. For
certain there are risks in doing this without surgical back up,
but in most people’s minds, the risk of harm if something
really goes wrong is outweighed by the potential benefits.
If the envelope is pushed farther, then what is the risk
versus benefit of elective PCI at hospitals without on-site
surgery? Lotfi et al. (7) may overestimate the risk, but maybe
not, because it is unlikely a hospital without on-site cardiac
surgery will have the same case volume and experience as a
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high-volume center with experienced operators. We may
never agree on the exact number, but given there is some
small but finite risk, is it outweighed by the benefit of
elective PCI in this setting? Treatment guidelines suggest
that elective PCI is appropriate for functionally significant
lesions to relieve angina (3). The relief of angina is a
wonderful thing for patients, but there are no data suggest-
ing PCI for the relief of angina lowers short-term mortality.
By definition, elective PCI cannot be urgent like the
treatment of STEMI, and the benefits are not dependent on
time. What then is the specific benefit? Those advocating
elective PCI in hospitals without on-site cardiac surgery
suggest there are geographic or socioeconomic factors that
limit access of the patient to hospitals with on-site surgery.
We can imagine an elderly couple living in a small town on
a fixed income who do not like to drive into the big city and
have no family or friends who are willing to help them. In
this circumstance perhaps, the expense of travel or drive on
the busy interstate highway is a barrier. However, could it be
possible that these geographic and economic factors relate
more to the physician or local hospital wanting the business
to stay in their own backyard? Whatever the risk of harm
attributed to a delay for urgent CABG surgery, the ultimate
question is whether any additional risk is acceptable in the
setting of elective PCI at a hospital without on-site surgical
back-up? In the final analysis, this becomes a comparison of
very serious risks that are unlikely to occur versus benefits
that are very soft end points.
Recently, there have been several expert opinions pub-
lished calling for specialized “Centers of Excellence” to treat
patients with acute coronary syndromes (25–27). This is
similar to the concept of trauma centers that have been
validated to improve outcomes. Although patients with
acute coronary syndromes are a high-risk group who often
require immediate treatment, does the Center of Excellence
concept also not make sense for elective PCI? Is the extra
risk something you would accept for your PCI?
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